For citations:
Osipova O.A., Gosteva E.V., Golivets T.P., Belousova O.N., Zemlyansky O.A., Pokrovsky M.V., Golovin A.I., Grigorenko N.V., Merezhko A.A. Changes of myocardial fibrosis markers with the use of beta-blockers and mineralocorticoid receptor antagonists in patients with heart failure with mid-range ejection fraction of ischemic origin. Cardiovascular Therapy and Prevention. 2021;20(7):3068. (In Russ.) https://doi.org/10.15829/1728-8800-2021-3068